Related Experiment Video
Updated: Sep 20, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Acute myocarditis according to age: Presentation, management and early outcomes
Clément Karsenty1,2, Paul Vignaud1, Clara Brusq3
1Department of Pediatric Cardiology, University Hospital, Toulouse, France.
Insights
Acute myocarditis (AM) presents differently in children and adults, with distinct causes and treatments. However, the 30-day prognosis for acute myocarditis is similar across all age groups.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Internal Medicine
Background:
- Acute myocarditis (AM) is a severe cardiac condition affecting all age groups.
- Limited multicenter studies exist comparing pediatric and adult AM cases.
- Understanding age-related differences is crucial for effective management.
Purpose of the Study:
- To investigate the differences in presentation, etiology, management, and outcomes of acute myocarditis between children and adults.
- To identify factors influencing AM severity and prognosis across pediatric and adult populations.
- To inform the development of tailored treatment strategies for AM.
Main Methods:
- A comprehensive French national cohort study analyzed 745 patients (328 children, 417 adults) from March 2020 to November 2021.
- Data collected included baseline characteristics, clinical evolution, management strategies, and in-hospital complications.
- Myocarditis-related events (MRE) within 30 days were defined as death, cardiogenic shock, cardiac arrest, ventricular arrhythmias, or complete AV block.
Main Results:
- Children presented with more severe symptoms, including higher rates of heart failure and cardiogenic shock, requiring more intensive support (inotropes, vasopressors, ventilation).
- Multisystem inflammatory syndrome (MIS) was more common in children (69.8%), while infectious causes predominated in adults (52.4%).
- Despite differing presentations and treatments (more corticosteroids/immunomodulators in children), 30-day MRE rates were comparable (18.1% in children vs. 13.4% in adults).
Conclusions:
- Acute myocarditis shows significant variations in presentation, etiology, and management between pediatric and adult patients.
- Despite these differences, the 30-day prognosis for acute myocarditis is similar in children and adults.
- Tailored management strategies are essential for optimizing acute myocarditis care across different age demographics.
Aims:
Acute myocarditis (AM) is a rare but severe disease affecting patients of all ages. Large multicentric studies comparing children and adults are currently lacking. We aimed to elucidate differences in presentation, management, and outcomes of AM across age groups.
Methods:
We analysed a comprehensive French national cohort study, encompassing 53 paediatric and adult units from March 2020 to November 2021, collecting data on baseline characteristics, evolution, management and in-hospital complications. Myocarditis-related events (MRE) within 30 days included all-cause death, cardiogenic shock, cardiac arrest, ventricular arrhythmias or complete AV block.
Results:
We included 745 AM patients (328 children and 417 adults), mainly male (73.4%) with a median age of 10.9 years [Q1-Q3 (7.3-14.6)] for children and 28.7 years [22.6-41.2] for adults. Multisystem inflammatory syndrome (MIS) was more prevalent among children (69.8%), and infectious aetiologies dominated in adults (13.4 vs. 52.4%). Children exhibited more severe clinical presentation (15.9 vs. 7.2%, P < 0.001, with heart failure and 14.4 vs. 6.9%, P < 0.001, with cardiogenic shock), requiring higher use of inotropes (25.0 vs. 9.4%, P < 0.001), vasopressors (12.0 vs. 6.2%, P < 0.001), and ventilatory support (13.7% vs. 7.9%, P = 0.01). Cardiac treatments were used less frequently in children, and corticosteroids (68.3 vs, 14.3, P < 0.001) and immunomodulators (65.1 vs. 4.5%, P < 0.001) were more common. MRE occurrence was substantial but not significantly different between children and adults (18.1 vs. 13.4%, P = 0.09). Extra-cardiac manifestations at admission were significant predictors of MRE [adjusted odds ratio 2.40 (1.43-4.38)], regardless of MIS status.
Conclusions:
AM exhibits variations in presentation, aetiologies and management but has a comparable 30 day prognosis in children and adults. These findings underscore the importance of tailored management strategies in AM across different age groups.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Endocarditis III: Medical Management
Myocarditis I: Introduction

